Periodontal pockets: A potential reservoir for SARS-CoV-2?

被引:76
|
作者
Badran, Zahi [1 ,2 ]
Gaudin, Alexis [3 ]
Struillou, Xavier [1 ]
Amador, Gilles [4 ]
Soueidan, Assem [1 ]
机构
[1] Univ Nantes, CHU Nantes, Dept Periodontol Rmes U1229, UIC 11,Fac Dent Surg, Nantes, France
[2] McGill Univ, Fac Dent, Montreal, PQ, Canada
[3] Univ Nantes, CHU Nantes, Dept Endodont Rmes U1229, UIC 11,Fac Dent Surg, Nantes, France
[4] Univ Nantes, CHU Nantes, Dept Dent Publ Hlth UPRES EA 3826, UIC 11,Fac Dent Surg, Nantes, France
关键词
VIRUSES; INFECTION; CELLS; HEALTHY; DISEASE;
D O I
10.1016/j.mehy.2020.109907
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Periodontal pockets are the major clinical manifestation of Periodontitis, a chronic inflammatory oral disease affecting the teeth-supporting tissues and has high prevalence in the adult population. Periodontal pockets are ideal environments for subgingival bacterial biofilms, that interact with the supragingival oral cavity, mucosal tissues of the pocket and a peripheral circulatory system. Periodontal pockets have been found to harbor viral species such as the Herpes simplex viruses' family. Recently, the SARS-CoV-2 has gained major interest of the scientific/medical community as it caused a global pandemic (Covid-19) and paralyzed the globe with high figures of infected people worldwide. This virus behavior is still partially understood, and by analyzing some of its features we hypothesized that periodontal pocket could be a favorable anatomical niche for the virus and thus acting as a reservoir for SARS-CoV-2.
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines
    Abdel-Moneim, Ahmed S.
    Abdelwhab, Elsayed M.
    Memish, Ziad A.
    VIROLOGY, 2021, 558 : 1 - 12
  • [32] SARS-COV-2 Variants: Differences and Potential of Immune Evasion
    Hirabara, Sandro M.
    Serdan, Tamires D. A.
    Gorjao, Renata
    Masi, Laureane N.
    Pithon-Curi, Tania C.
    Covas, Dimas T.
    Curi, Rui
    Durigon, Edison L.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 11
  • [33] The potential effects of clinical antidiabetic agents on SARS-CoV-2
    Qu, Hua
    Zheng, Yi
    Wang, Yuren
    Li, Hongwei
    Liu, Xiufei
    Xiong, Xin
    Zhang, Linlin
    Gu, Jing
    Yang, Gangyi
    Zhu, Zhiming
    Zheng, Hongting
    Ouyang, Qin
    JOURNAL OF DIABETES, 2021, 13 (03) : 243 - 252
  • [34] Potential mechanisms of mediastinum involvement in SARS-COV-2 infection
    Giannaki, Maria
    Antoniadis, Antonis
    PNEUMON, 2020, 33 (04) : 171 - 174
  • [35] Potential secondary transmission of SARS-CoV-2 via wastewater
    Liu, Dasheng
    Thompson, Julian R.
    Carducci, Annalaura
    Bi, Xuejun
    SCIENCE OF THE TOTAL ENVIRONMENT, 2020, 749
  • [36] Potential antiviral effects of pantethine against SARS-CoV-2
    Abou-Hamdan, M.
    Saleh, R.
    Mani, S.
    Dournaud, P.
    Metifiot, M.
    Blondot, M. L.
    Andreola, M. L.
    Abdel-sater, F.
    De Reggi, M.
    Gressens, P.
    Laforge, M.
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [37] Potential SARS-CoV-2 vaccines: Concept, progress, and challenges
    Hosseini, Seyede Atefe
    Zahedipour, Fatemeh
    Mirzaei, Hamed
    Oskuee, Reza Kazemi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 97
  • [38] Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach
    Rolta, Rajan
    Salaria, Deeksha
    Sharma, Bhanu
    Awofisayo, Oladoja
    Fadare, Olatomide A.
    Sharma, Sonum
    Patel, Chirag N.
    Kumar, Vikas
    Sourirajan, Anuradha
    Baumler, David J.
    Dev, Kamal
    CURRENT PHARMACOLOGY REPORTS, 2022, 8 (02) : 149 - 170
  • [39] Potential therapeutic effects of Resveratrol against SARS-CoV-2
    Ramdani, L. H.
    Bachari, K.
    ACTA VIROLOGICA, 2020, 64 (03) : 276 - 280
  • [40] SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation
    MacDougall, Madison
    Sleiman, Jad El-Hajj
    Beauchemin, Philippe
    Rangachari, Manu
    FRONTIERS IN IMMUNOLOGY, 2022, 13